HealthEquity’s (HQY) Outperform Rating Reaffirmed at Barrington Research

Barrington Research reissued their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a report published on Friday,Benzinga reports. They currently have a $112.00 price objective on the stock.

Several other analysts also recently issued reports on the company. Raymond James boosted their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price objective for the company. BTIG Research lifted their price objective on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. Finally, Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $112.92.

HealthEquity Stock Performance

HQY opened at $97.41 on Friday. The business has a fifty day simple moving average of $105.68 and a 200 day simple moving average of $95.35. The company has a market capitalization of $8.44 billion, a PE ratio of 89.37, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently bought and sold shares of the company. ABLE Financial Group LLC increased its holdings in HealthEquity by 8.5% in the 4th quarter. ABLE Financial Group LLC now owns 21,725 shares of the company’s stock worth $2,085,000 after purchasing an additional 1,709 shares in the last quarter. Forum Financial Management LP acquired a new position in HealthEquity in the 4th quarter worth about $214,000. Public Employees Retirement System of Ohio increased its holdings in HealthEquity by 6.1% in the 4th quarter. Public Employees Retirement System of Ohio now owns 97,323 shares of the company’s stock worth $9,338,000 after purchasing an additional 5,569 shares in the last quarter. GTS Securities LLC acquired a new position in HealthEquity in the 4th quarter worth about $239,000. Finally, AlphaQ Advisors LLC acquired a new position in HealthEquity in the 4th quarter worth about $313,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.